French drug developer Ethypharm acquires UK-based Martindale Pharma
Ethypharm has signed a definitive agreement to acquire Martindale Pharma.
List view / Grid view
News
Researchers discover severe side effects of approved multiple sclerosis medication
20 January 2017 | By Niamh Marriott, Digital Editor
The multiple sclerosis therapy alemtuzumab can trigger severe, unpredictable side effects...
Panacea initiates Phase I prostate cancer vaccine therapy trial
19 January 2017 | By Niamh Marriott, Digital Editor
Panacea Pharmaceuticals have enrolled and dosed the first patient in the open-label, parallel designed, multi-centre Phase I clinical trial of PAN-301-1, for the treatment of persistent prostate cancer to assess safety and immunogenicity. Clinical sites for the PAN-301-1 trial are located in Alabama, California, Nebraska and South Carolina and the…
EU approval for Sanofi’s type 2 diabetes treatment
19 January 2017 | By Niamh Marriott, Digital Editor
Suliqua is an innovative new combination therapy that has the potential to address significant unmet needs for people living with type 2 diabetes in Europe
Eli Lilly to aquire pain biotech CoLucid for $960 million
19 January 2017 | By Niamh Marriott, Digital Editor
This transaction will be acting to enhance Lilly's existing portfolio in pain management for migraine, while adding a potential near-term launch...
AgileBio announces a new mobile app: LabCollector Stock Manager
19 January 2017 | By AgileBio
AgileBio announces a new app for mobile phones...
Ensuring moisture-analysis accuracy with enhanced process security
16 January 2017 | By Mettler Toledo
METTLER TOLEDO’s firmware version 2.20 for its Excellence Moisture Analyzers HX204 and HS153 allows individual methods assignment to ensure users follow SOPs and avoid mistakes. This added level of security saves time and helps to eliminate costly rework...
FDA extends review period for Eli Lilly’s rheumatoid arthritis drug
16 January 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has extended the review period for Eli Lilly and Incyte’s new drug application for investigational baricitinib, a once-daily oral medication for the treatment of moderate to severe rheumatoid arthritis (RA).
FDA accepts Mylan and Biocon’s biosimilar biologics license application
12 January 2017 | By Niamh Marriott, Digital Editor
This product is a proposed biosimilar to branded trastuzumab, which is indicated to treat certain HER2-positive breast cancers...
Ablynx initiates Phase IIb anti-RSV nanobody trial for infants
12 January 2017 | By Niamh Marriott, Digital Editor
Topline results from this Phase IIb study to treat children with RSV with inhaled ALX-0171 are expected in the second half of 2018...
BioPharma leaders call for gender diversity
12 January 2017 | By Niamh Marriott, Digital Editor
More than 100 prominent life sciences executives, investors, and business leaders have signed an open letter calling on the industry to increase gender diversity...
NICE approves former CDF kidney cancer drug for NHS use
12 January 2017 | By Niamh Marriott, Digital Editor
Everolimus (Afinitor, Novartis) is now recommended to be available on the NHS as a treatment option for some patients with advanced renal cell carcinoma...
Phase II trial for F2G’s antifungal drug following EU approval
11 January 2017 | By Niamh Marriott, Digital Editor
F901318 is the first member of a novel class of systemic antifungal agents targeting life threatening mould infections and acting through a target...
NHS Confederation appoints Niall Dickson as new Chief Executive
11 January 2017 | By Niamh Marriott, Digital Editor
The NHS Confederation today announced the appointment of Niall Dickson as its new Chief Executive.
Dolomite Bio launches Injection Valve and Sample Loop for scRNA-Seq
10 January 2017 | By Dolomite Bio
Dolomite Bio has launched a new Injection Valve and Sample Loop for single cell RNA sequencing workflows...
